J. S. Kaltenbronn

发表

Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.

A. Sefler, W. L. Cody, D. Leonard, 1995, Journal of medicinal chemistry.

Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors.

A. Doherty, M. J. Ryan, M. Taylor, 1992, Journal of medicinal chemistry.

The design of potent hexapeptide endothelin antagonists stable to proteolysis

A. Doherty, B. H. Stewart, E. Reyner, 1995 .

Antiinflammatory activity of isomeric phenylnaphthaleneacetic acids.

J. S. Kaltenbronn, 1977, Journal of medicinal chemistry.

Design and synthesis of renin inhibitors: incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of P3-modified renin inhibitors.

C. Humblet, E. Lunney, A. Doherty, 1995, Journal of medicinal chemistry.

Functionalization of substituted 2(1H)‐ and 4(1H)‐pyridones. III. The preparation of substituted 6‐Vinyl‐1,2‐dihydro‐2‐oxo‐ and 1,4‐dihydro‐4‐oxo‐3‐pyridinecarboxylic acids through the chemistry of pyridone dianions

J. Domagala, D. Dejohn, J. S. Kaltenbronn, 1983 .

CI-867, a new broad-spectrum semisynthetic penicillin.

T. Haskell, C. L. Heifetz, D. Dejohn, 1979, The Journal of antibiotics.

Renin inhibitors containing isosteric replacements of the amide bond connecting the P3 and P2 sites.

E. Lunney, E. Nicolaides, M. Stier, 1990, Journal of medicinal chemistry.

New inhibitors of human renin that contain novel replacements at the P2 site.

A. Doherty, M. Taylor, J. C. Hodges, 1991, Journal of medicinal chemistry.

Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acids.

C. J. Blankley, A. Werner, M. Hoefle, 1987, Journal of medicinal chemistry.

Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate.

C. Humblet, E. Lunney, J. C. Hodges, 1991, Journal of medicinal chemistry.

Anti-writhing activity of some peptides related to neurotensin and tuftsin.

E. Lunney, E. Nicolaides, D. A. Downs, 2009, International journal of peptide and protein research.

Analyses of ligand binding in five endothiapepsin crystal complexes and their use in the design and evaluation of novel renin inhibitors.

J. Cooper, E. Lunney, W. Lowther, 1993, Journal of medicinal chemistry.

Synthesis of a Bromine-Rich Marine Antibiotic

S. Hanessian, J. S. Kaltenbronn, 1966 .

5-Aryl-2-furanacetic acids.

J. S. Kaltenbronn, T. O. Rhee, 1968, Journal of medicinal chemistry.

C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice.

A. Doherty, D. Mcnamara, E. Dobrusin, 1997, Journal of medicinal chemistry.

553. The absolute configuration of rotenone

L. Crombie, P. Godin, G. Büchi, 1961 .

Modified di- and tripeptides of the C-terminal portion of oxytocin and vasopressin as possible cognition activation agents.

E. Lunney, E. Nicolaides, R. Davis, 1986, Journal of medicinal chemistry.